Actively Recruiting
The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome
Led by Fondazione IRCCS Policlinico San Matteo di Pavia · Updated on 2025-12-10
60
Participants Needed
1
Research Sites
13 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying patients with eosinophilic granulomatosis with polyangiitis (EGPA) and hypereosinophilic syndrome (HES) to collect clinical, laboratory, and instrumental data. The goal is to use artificial intelligence to identify characteristics that differentiate these two diseases and predict how patients might respond to treatment. This study aims to improve diagnosis and treatment decision-making for these conditions. Participants will undergo blood draws for laboratory assessments as part of the study procedures. These data will be analyzed using machine learning techniques to find meaningful differences between EGPA and HES. The study focuses on gathering information rather than testing a new drug or treatment. During the study, participants will provide clinical and laboratory data, including blood samples. Researchers will monitor these data over an 18-month period to identify distinct disease features. The study involves no masking or placebo, and participants will be followed to assess characteristics that separate the two conditions. The total participation time corresponds to the data collection period of 18 months.
CONDITIONS
Brief Title
The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or over
- A diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) or hypereosinophilic syndrome (HES)
- Willing and able to give informed written consent, or permission for a nominated friend or relative to provide written consent if unable due to physical disabilities
You will not qualify if you...
- Lack of a confirmed diagnosis of EGPA or HES
- Presence of other causes of eosinophilia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Trial Site Locations
Total: 1 location
1
Fondazione IRCCS Policlinico San Matteo, SC Reumatologia
Pavia, Italy, 27100
Actively Recruiting
Research Team
C
Carlomaurizio Montecucco
A
Alessandra Milanesi
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here